Global Risks

Here's why some people with coronavirus get symptoms while others don't

Emergency Medical Technicians (EMT) wearing protective gears wheel a sick patient to a waiting ambulance during the outbreak of coronavirus disease (COVID-19) in New York City, New York, U.S., March 28, 2020.  REUTERS/Stefan Jeremiah - RC24TF97DNX6

Everything you need to know on coronavirus symptoms. Image: REUTERS/Stefan Jeremiah

Abela Mahimbo
Lecturer in Public Health, University of Technology Sydney
David Isaacs
Professor of Pediatric Infectious Diseases, University of Sydney
Melanie Wong
Head of Diagnostic Immunology Laboratory, Kids Research
Melissa Kang
Associate professor, University of Technology Sydney
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on Global Risks?
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

COVID-19

  • Research has shown that as many as 80% of those infected could show no or mild symptoms, generally these are people from a young, healthy demographic.
  • Having a strong immune response during the incubation period can prevent the infection taking hold, reduce the actual quantity of virus in the body and prevent it from getting to the lungs.
  • Yet an excessive immune response can actually cause so much inflammation it can be fatal.

SARS-CoV-2, the coronavirus which causes COVID-19, has infected almost 2.5 million people around the world and claimed 170,000 lives.

But some people don’t even get symptoms. Recent studies suggest as many as 80%

or more of those infected are “silent carriers”, showing no or very mild symptoms.

It seems children and young, healthy people are more likely to be asymptomatic.

But to calculate the true proportions of people who have no symptoms right through to severe illness, testing would need to be expanded across whole populations, and this hasn’t been feasible yet.

We don’t know exactly why some people with coronavirus are asymptomatic while others develop life-threatening illness. But here’s what we know so far.

Have you read?

What happens when coronavirus enters your body?

Like all viruses, SARS-CoV-2 needs to get inside human cells to multiply and survive.

To do this, a particle on the outer shell of the virus latches onto a matching protein receptor, called ACE2, like a lock and key. ACE2 receptors are normally found in the lungs, kidneys, heart and the gut.

coronavirus fears epidemic pandemic disease infection contamination sanitation spread virus health care
Here the SARS-CoV-2 virus (in green and orange) attaches to the ACE2 receptor (in pink). Image: Shutterstock

Once a person has been infected with the virus, it can take up to 14 days for symptoms to appear (if they do at all) – known as the incubation period.

The path from the point of infection can vary enormously. The body’s immune system is critical for determining this.

Having a strong immune response during the incubation period can prevent the infection taking hold, reduce the actual quantity of virus in the body and prevent it from getting to the lungs.

Some immune response basics

Our immune system offers us two lines of defence against viruses.

The first is the innate system and includes physical barriers such as skin and mucous membranes (the lining of the throat and nose), various proteins and molecules found in tissues, as well as some of the white blood cells that attack invading organisms. This immune response is general, non-specific and kicks in quickly.

Children have immature immune systems, but one hypothesis to explain why they don’t seem to get as sick with COVID-19 is that their innate immune response to coronavirus is greater than in adults.

This may lead to a reduced viral load – the quantity of virus particles that survive in the body – because they’re able to clear the virus more quickly.

coronavirus fears epidemic pandemic disease infection contamination sanitation spread virus health care italy quarantine home isolation social distancing
Children’s resilience to coronavirus might be due to their innate immune response. Image: Shutterstock

The second line of defence is the adaptive immune response. This takes longer to initiate but once established, is much more efficient at eradicating a specific infection when encountering it again.

It’s thought that very specific genetic variations in some people might play a part in how sick they get. By generating an early adaptive immune response, the body seems to recognise the virus during the incubation period and fight it off.

A person also needs to be generally healthy to be able to mount an appropriate immune response to the infection.

After the incubation period, what determines how sick you get?

If the SARS-CoV-2 virus survives beyond the point of entry to the body (nose, eyes, throat) it might then make its way down the respiratory tract into the lungs.

In the lungs, it latches onto ACE2 receptors and continues replicating itself, triggering further immune responses to clean out infected cells. The amount of virus that gets deep into the lungs may be another important factor determining how sick you get.

As the battle between virus and immune responses proceeds, infected airway linings produce large amounts of fluid that fill the air sacs, leaving less room for transferring oxygen into the bloodstream and removing carbon dioxide.

Symptoms of pneumonia appear, such as fever, cough with sputum (phlegm) and shortness of breath.

coronavirus work pandemic from home remote productivity interruptions focus efficiency task job employment career
Fluid in the lungs makes it difficult to breathe. Image: Shutterstock

For some people, the immune response is excessive or prolonged and causes what’s known as a “cytokine storm”. Cytokines are a group of proteins that send signals to cells in the immune system, helping direct the response.

A cytokine storm is a catastrophic overreaction that causes so much inflammation and organ damage, it can be fatal.

In people with COVID-19, as well as the previous SARS and MERS coronaviruses, this causes acute respiratory distress syndrome (ARDS), when fluid builds up in the lungs. This is the most common cause of death from SARS-CoV-2.

Elderly people and those with chronic lung disorders are more likely to develop ARDS and therefore to die. This is currently thought to be due to these groups of people having fewer ACE2 receptors in their lungs.

This seems counter-intuitive, because the virus attaches itself to these receptors. However, ACE2 receptors have an important role in regulating the immune response, particularly in managing the degree of inflammation.

So the reduced levels of ACE2 receptors in the elderly may actually make them more at risk of a cytokine storm and severe lung disease.

Conversely, children have more ACE2 receptors in their lungs which might explain why they do not get as sick.

In some cases, medications that work to suppress the immune system have successfully treated this excessive immune response in people with COVID-19.

coronavirus nature environment climate change cities urban life streets deserted pollution traffic cars noise air clean
Older people’s immune systems respond very differently to children’s. Image: Shutterstock

Can people without symptoms pass it on?

Some studies have indicated people with COVID-19 tend to have a high viral load just before and shortly after they start getting symptoms.

This suggests they can transmit it when they first get sick and up to 48 hours before, while they’re pre-symptomatic.

However, there is no good evidence that asymptomatic people who never develop symptoms are able to pass it on.

Researchers and clinicians are working around the clock to understand the complex relationship between humans’ immune systems and SARS-CoV-2 but it remains very much a work in progress.

Loading...
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
Global RisksHealth and Healthcare Systems
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

G7 Summit talking points: From Ukraine and Gaza to the impact of AI

David Elliott

June 18, 2024

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum